Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Urinary DNA-methylation and protein biomarkers identify urothelial carcinoma among other genitourinary diseases and cancer-free individuals.

Journal of translational medicine·2024

Same author

Correction to: Stroke‑derived neutrophils demonstrate higher formation potential and impaired resolution of CD66b + driven neutrophil extracellular traps.

BMC neurology·2023

Same author

Stroke-derived neutrophils demonstrate higher formation potential and impaired resolution of CD66b + driven neutrophil extracellular traps.

BMC neurology·2022

Same author

Mismatch Repair Protein Expression and Microsatellite Instability in Cutaneous Squamous Cell Carcinoma.

Current oncology (Toronto, Ont.)·2021

Same author

Expression of Mismatch Repair Proteins in Merkel Cell Carcinoma.

Cancers·2021

Same author

In-Vitro Identification and In-Vivo Confirmation of DNA Methylation Biomarkers for Urothelial Cancer.

Biomedicines·2020

Same journal

A Phase I Open-label Study of the Safety, Tolerability, and Pharmacokinetics of NHWD-870 HCl in Patients with Lymphoma and Other Advanced Solid Tumors.

Recent patents on anti-cancer drug discovery·2026

Same journal

Integrated Proteomics and Metabolomics Analysis Provides Insights into Metformin Down-regulating GLUL and SP1 to Inhibit Esophageal Squamous Cell Carcinoma Migration and Invasion.

Recent patents on anti-cancer drug discovery·2026

Same journal

SEZ6L2 Promotes Cervical Carcinogenesis by Activating the Wnt Signaling Pathway.

Recent patents on anti-cancer drug discovery·2026

Same journal

Shengma Biejia Decoction Suppresses Acute Myeloid Leukemia by Regulating Mitochondrial Dynamics through the PI3K/AKT Signaling Pathway.

Recent patents on anti-cancer drug discovery·2026

Same journal

Spatial and Single-cell Multi-omics Approaches Unravel the Genetic and Immunological Landscape of SIRPB1 in Kidney Renal Clear Cell Carcinoma.

Recent patents on anti-cancer drug discovery·2026

Same journal

Exploring the Active Components and Mechanisms of Schisandra Chinensis for Treatment of Non-small Cell Lung Cancer Based on Network Pharmacology and Experimental Validation.

Recent patents on anti-cancer drug discovery·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jul 8, 2026

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

Published on: June 16, 2018

Inhibitors for metastasis development.

Kerstin Lang¹, Theodore L Drell, Kurt S Zaenker

¹Institute of Immunology, Witten/Herdecke University, Witten, Germany.

Recent Patents on Anti-Cancer Drug Discovery

|January 29, 2008

Summary

This summary is machine-generated.

Preventing cancer metastasis, the spread of cancer cells, is crucial for reducing cancer deaths. This review explores metastasis mechanisms and potential pharmacological inhibition strategies.

More Related Videos

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Published on: September 26, 2016

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

Published on: December 26, 2016

Related Experiment Videos

Last Updated: Jul 8, 2026

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

Published on: June 16, 2018

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Published on: September 26, 2016

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

Published on: December 26, 2016

Area of Science:

Oncology
Molecular Biology
Pharmacology

Background:

Cancer is a leading cause of death globally.
Early-stage cancer is often treatable, but distant metastasis significantly increases mortality.
Understanding metastasis is key to developing effective cancer therapies.

Purpose of the Study:

To review the current understanding of cellular and molecular mechanisms driving cancer metastasis.
To identify and suggest potential pharmacological strategies for inhibiting metastasis development.

Main Methods:

Literature review of current research on cancer metastasis.
Analysis of cellular and molecular pathways involved in metastasis.
Synthesis of findings to propose inhibition approaches.

Main Results:

Metastasis involves complex cellular and molecular processes.
Several key pathways are implicated in cancer cell spread.
Pharmacological interventions targeting these pathways show promise.

Conclusions:

Targeting metastasis is a critical goal in cancer research.
Further research into the mechanisms of metastasis can lead to novel therapeutic strategies.
Pharmacological inhibition of metastasis could improve patient survival rates.